share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Trizzino John

Novavax | 4: Statement of changes in beneficial ownership of securities

諾瓦瓦克斯醫藥 | 4:持股變動聲明
美股sec公告 ·  03/26 19:05
Moomoo AI 已提取核心訊息
John Trizzino, the Executive Vice President, Chief Commercial Officer, and Chief Business Officer (EVP, CCO, and CBO) of Novavax, Inc. [NVAX], was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The address provided for John Trizzino is c/o Novavax, Inc., located at 700 Quince Orchard Road, Gaithersburg, MD, 20878. The transaction's impact on Trizzino's total holdings in Novavax was not included in the provided information.
John Trizzino, the Executive Vice President, Chief Commercial Officer, and Chief Business Officer (EVP, CCO, and CBO) of Novavax, Inc. [NVAX], was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The address provided for John Trizzino is c/o Novavax, Inc., located at 700 Quince Orchard Road, Gaithersburg, MD, 20878. The transaction's impact on Trizzino's total holdings in Novavax was not included in the provided information.
據報道,Novavax, Inc. [NVAX] 的執行副總裁、首席商務官兼首席商務官(執行副總裁、首席財務官和首席商務官)約翰·特里齊諾於2024年3月1日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節,包括股票數量、股票性質、交易價格和股票總價值。爲約翰·特里齊諾提供的地址是 c/o Novavax, Inc.,位於馬里蘭州蓋瑟斯堡昆斯烏查德路700號,郵編20878。該交易對Trizzino在Novavax的總持股量的影響未包含在提供的信息中。
據報道,Novavax, Inc. [NVAX] 的執行副總裁、首席商務官兼首席商務官(執行副總裁、首席財務官和首席商務官)約翰·特里齊諾於2024年3月1日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節,包括股票數量、股票性質、交易價格和股票總價值。爲約翰·特里齊諾提供的地址是 c/o Novavax, Inc.,位於馬里蘭州蓋瑟斯堡昆斯烏查德路700號,郵編20878。該交易對Trizzino在Novavax的總持股量的影響未包含在提供的信息中。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息